نتائج البحث

تحتوي على الكلمات

فقط من النوع

Single arm Phase I/II study of the safety, tolerability and efficacy of the investigational anti PD-L1 monoclonal antibody Durvalumab in combination with Paclitaxel in patients with metastatic triple negative PD-L1 positive breast cancer قائمة الدراسات السريرية المسجلة على الادوية

An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia قائمة الدراسات السريرية المسجلة على الادوية

A randomized, double-blinded placebo-controlled, phase 3, parallel-group design study evaluating the efficacy and safety of Efgartigimod PH20 SC Administered by prefilled syringe in adults participants with ocular MG قائمة الدراسات السريرية المسجلة على الادوية

Diphtheria Toxoid/ Pertussis toxoid/ Tetanus Toxoid/ Filamentous haemagglutinin/ Inactivated Poliomyelitis virus type 1 (Mahoney strain)/ Inactivated Poliomyelitis virus type 2 (MEF-1 strain)/ Inactivated Poliomyelitis virus type 3 (Saukett strain) قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. قائمة الدراسات السريرية المسجلة على الادوية

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Amlodar Capsules (10 mg amlodipine) Produced by Dar AlDawa / Jordan versus Amlor® Capsules (10 mg amlodipine) Produced by Pfizer / KSA, in healthy subjects under fasting condition. قائمة الدراسات السريرية المسجلة على الادوية

A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) قائمة الدراسات السريرية المسجلة على الادوية

A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk قائمة الدراسات السريرية المسجلة على الادوية

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of brigimadlin (BI 907828) for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours قائمة الدراسات السريرية المسجلة على الادوية

A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer قائمة الدراسات السريرية المسجلة على الادوية